We help you to finance your cancer research project

If you are conducting a research project focused on any type of cancer, ABYNTEK RESEARCH REAGENTS can help you.

ABYNTEK RESEARCH REAGENTS is a brand with a social commitment to the fight against cancer. It is a range of the highest quality bioreagents for oncology research, including more than 46,000 references of antibodies, proteins and ELISA/CLIA kits for the study of hundreds of biomarkers of different types of cancer.

But beyond the commitment to quality towards our clients and researchers, we want our work to transcend and result in a firm social commitment.

“Abyntek Research Reagents fulfils a dual purpose. On the one hand, to provide the scientific community with a wide range of the highest quality bioreagents for cancer research, and on the other, to contribute to supporting cancer research by funding projects focused on this cause “

We are fully aware of the difficulty involved in developing a research project in terms of time and investment, and sometimes finding funds is very complicated. That is why from Abyntek Biopharma we have decided to facilitate the work of researchers by providing up to € 3,000 in reagents per selected project.

Applying is as simple as being a customer of ABYNTEK RESEARCH REAGENTS product line and filling out the form on this page.

We will contact you to know more about your project and, if your research project is selected, we will refund the amount invoiced from September 1, 2022 to March 31, 2023 on ABYNTEK RESEARCH REAGENTS products to be redeemed on ABYNTEK RESEARCH REAGENTS references up to a maximum of 3,000€ until December 31, 2023.

Read the full terms and conditions of the competition here.

APPLY NOW!


ABYNTEK RESEARCH REAGENTS offers a wide range of high quality bioreagents for cancer research.

If you need assistance when selecting the bioreagent that best suit your research, we will be happy to advise you. Tell us your needs and we will help you find the optimal solution. Contact us!

Pin It on Pinterest

Share This